Your session is about to expire
← Back to Search
PRP Injections for Jumper's Knee (PRP Trial)
PRP Trial Summary
This trial will compare platelet-rich plasma injections to a control group in order to determine if they improve clinical outcomes for chronic patellar tendinopathy. A new ultrasound imaging assessment called Acoustoelastography will be used to help determine the results.
PRP Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowPRP Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.PRP Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am currently using opioids for pain management.I have had knee tendon pain for more than 3 months.I am currently using or have recently used blood thinners or drugs that weaken my immune system.I am between 18 and 65 years old.I have tried at least 2 common treatments for knee tendon pain without success.My knee pain is caused by a condition like arthritis.My knee has been diagnosed with patellar tendonitis.I have a history of bleeding disorders or low blood platelet counts.
- Group 1: Platelet Rich Plasma
- Group 2: Group 2
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
How could Platelet Rich Plasma potentially put participants at risk?
"Our research team assigned a score of 2 to Platelet Rich Plasma in terms of safety, as there are data points which indicate its security but no efficacy evidence."
What are the criteria for joining this experiment?
"This clinical trial is seeking 44 individuals aged 18-65 with a diagnosis of chronic patellar tendinopathy. The selection criteria are as follows: age18-65, prolonged (>3months) tendon pain in the knee; physical examination findings congruent with PT; self-reported unsuccessful treatment through supervised physical therapy and two other common treatments (NSAIDs, relative rest, ice, bracing)."
Is there an age restriction on the participants of this research?
"According to this trial's enrollment parameters, only individuals aged 18-65 are eligible for participation."
What goal is the clinical trial attempting to accomplish?
"Over the course of 12 months, this clinical trial will measure its efficacy by analysing changes in International Knee Documentation Committee (IKDC) Score. Secondary outcomes include a comparison of patellar tendon thickness between limbs using ultrasound imaging and an assessment of neovascularity within the tendon through conventional ultrasounds. To analyse stiffness shifts across tendons, acoustoelastography is used with standardised 0-3 severity scales compared to control subjects."
Are potential participants currently being accepted for this research endeavor?
"Data from clinicaltrials.gov confirms that this research project is not presently searching for patients, despite having been posted on January 1st 2014 and last updated October 6th 2022. However, there are 74 different trials actively recruiting participants at the moment."
Share this study with friends
Copy Link
Messenger